Hurdles to Specialty Pharmacy Success Highlights SPT Week in Review

5. Cancer in HIV-Positive Population Expected to Decline by 2030

Decline in cancer incidence rates most likely driven by modern antiretroviral therapies.

https://www.specialtypharmacytimes.com/news/cancer-in-hiv-positive-population-expected-to-decline-by-2030

4. AllianceRx Walgreens Prime Seeks to Revolutionize Specialty Pharmacy Care

First of its kind pharmacy aligns a pharmacy benefit manager and a retail giant.

https://www.specialtypharmacytimes.com/news/alliancerx-walgreens-prime-seeks-to-revolutionize-specialty-pharmacy-care

3. Multiple Myeloma Patient Steps Up to Bat to Advocate for Cancer Patients

Multiple myeloma survivor seeks to empower patients by illustrating the value of human life.

https://www.specialtypharmacytimes.com/news/multiple-myeloma-patient-steps-up-to-bat-to-advocate-for-cancer-patients

2. Ribavirin-Free Treatment Shows Promise in Chronic Hepatitis C Virus

Glecaprevir/pibrentasvir achieved 99% sustained virologic response rate in patients with chronic HCV with compensated cirrhosis.

https://www.specialtypharmacytimes.com/news/ribavirin-free-treatment-shows-promise-in-chronic-hepatitis-c-virus

1. What Does the Future Hold for Specialty Pharmacy?

Challenges to specialty pharmacy profits will need to be overcome for smaller pharmacies to survive.

https://www.specialtypharmacytimes.com/news/what-does-the-future-hold-for-specialty-pharmacy